Skip to content
healthcare.dev

Glycyrrhiza Glabra

NDC 37662-0766, Glycyrrhiza Glabra, pellet, from Hahnemann Laboratories, INC..

Product NDC
37662-0766
Status
Listed
Labeler
Hahnemann Laboratories, INC.
Dosage form
PELLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/37662-0766 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCYRRHIZA GLABRA100 [hp_C]/1

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]

Package NDCNDC-11Package
37662-0766-137662076601200 PELLET in 1 VIAL, GLASS (37662-0766-1)
37662-0766-237662076602500 PELLET in 1 VIAL, GLASS (37662-0766-2)
37662-0766-3376620766033000 PELLET in 1 BOTTLE, GLASS (37662-0766-3)
37662-0766-43766207660410000 PELLET in 1 BOTTLE, GLASS (37662-0766-4)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 37662-0766 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/37662-0766 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 37662-0766. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.